Australia, Jan. 28 -- Ambry Genetics Corp., owns the trademark (2601336) for 'NEURODEVELOPMENTNEXT' till Oct. 7, 2035.
Status: protected:
Registered/protected
Class: 44 [Medical screening; medical testing for diagnostic or treatment purposes; DNA screening for medical purposes.]
Type of Mark: Word
Date of Acceptance: Nov. 18, 2025
Registration Advertised: Jan. 27
For further details contact Carrie L. Kiedrowski Jones Day.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2601336.
Disclaimer: Curated by HT Syndication....